Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.


TSXV:QPT - Post by User

Comment by ARIMA11on Aug 20, 2021 11:41am
151 Views
Post# 33739846

RE:RE:RE:RE:What am I missing.

RE:RE:RE:RE:What am I missing.No worries. Everything seems to be taking alot longer than anticipated.
https://oqp.co.kr/ir/notice/?uid=41&mod=document&pageid=1

Notice of change of division plan
OncoQuest Pharmaceuticals Co., Ltd. decided to partially change the spin-off plan approved at the extraordinary general meeting of shareholders on July 23, 2021 as follows at the board of directors held on July 27, 2021. This change of the spin-off plan is to change the ‘[Attachment 2] List of assets subject to succession [Assets and liabilities to be divided into the newly established company 2]’ in the spin-off plan approved through the existing extraordinary general meeting of shareholders to ‘7. Other important matters in the division plan (1) In accordance with the provisions on the amendment and change of the division plan, the change is made to the resolution of the Board of Directors of OncoQuest Pharmaceuticals Co., Ltd.
Accordingly, we report the following to each shareholder through this notice

<< Previous
Bullboard Posts
Next >>